熱門資訊> 正文
确认GAAP每股收益为-1.01欧元，收入为20万欧元
2024-09-05 18:31
- Affimed press release (NASDAQ:AFMD): Q2 GAAP EPS of -€1.01.
- Revenue of €0.2M (-85.7% Y/Y).
- As of June 30, 2024, cash, cash equivalents and investments were €34.4 million. Based on operating and financial plans cash-runway projected into H2 2025.
More on Affimed
- Affimed Follow Up: Upcoming Acimtamig And AFM24 Updates Could Be Positive Catalysts
- Affimed says 86% of patients responded to lymphoma therapy in mid-stage trial
- Seeking Alpha’s Quant Rating on Affimed
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
